Evidence map›Paper›PMID 34412939›Full record

ArticleMolecular genetics and metabolism

Functional analysis of a de novo variant in the neurodevelopment and generalized epilepsy disease gene NBEA.

Thomas Boulin, Omar Itani, Sonia El Mouridi, Alice Leclercq-Blondel, Marie Gendrel, Ellen Macnamara, Ariane Soldatos, Jennifer L Murphy, Mark P Gorman, Anika Lindsey and 8 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Molecular genetics and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02450851 (Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Frontiers in neuroscience · 2025
    Article
  6. Null MutantmicroPublication biology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

Thomas BoulinInstitut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon 69008, France.
Omar ItaniC. elegans Model Organism Screening Center, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA; Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Sonia El MouridiInstitut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon 69008, France.
Alice Leclercq-BlondelInstitut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon 69008, France.
Marie GendrelInstitut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon 69008, France; Institut de Biologie de l'Ecole Normale Supérieure (IBENS), Ecole Normale Supérieure, CNRS, INSERM, Université Paris Sciences et Lettres Research University, Paris 75005, France.
Ellen MacnamaraUndiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
Ariane SoldatosUndiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
Jennifer L MurphyUndiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
Mark P GormanDepartment of Neurology, Neuroimmunology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Anika LindseyC. elegans Model Organism Screening Center, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA; Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Shino ShimadaUndiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
Darian TurnerC. elegans Model Organism Screening Center, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA; Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Gary A SilvermanDepartment of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Dustin BaldridgeDepartment of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Undiagnosed Diseases Network
May C MalicdanUndiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
Tim SchedlC. elegans Model Organism Screening Center, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA; Department of Genetics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA.
Stephen C PakC. elegans Model Organism Screening Center, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA; Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO 63110, USA. Electronic address: stephen.pak@wustl.edu.
Washington University in St. Louis · USNational Institutes of Health · USCentre National de la Recherche Scientifique · FRNational Human Genome Research Institute · USBoston Children's Hospital · USInstitut NeuroMyoGène · FRUniversité Claude Bernard Lyon 1 · FR

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Zebrafish Resource CoreU54NS108251 · NINDS · WASHINGTON UNIVERSITY · PI SCHEDL, TIM, SOLNICAKREZEL, LILIANNA · 2018 to 2022
$2.3M
NIH HHS P40 OD010440NINDS NIH HHS U54 NS108251
6 · The paper itself

Abstract

Neurobeachin (NBEA) was initially identified as a candidate gene for autism. Recently, variants in NBEA have been associated with neurodevelopmental delay and childhood epilepsy. Here, we report on a novel NBEA missense variant (c.5899G > A, p.Gly1967Arg) in the Domain of Unknown Function 1088 (DUF1088) identified in a child enrolled in the Undiagnosed Diseases Network (UDN), who presented with neurodevelopmental delay and seizures. Modeling of this variant in the Caenorhabditis elegans NBEA ortholog, sel-2, indicated that the variant was damaging to in vivo function as evidenced by altered cell fate determination and trafficking of potassium channels in neurons. The variant effect was indistinguishable from that of the reference null mutation suggesting that the variant is a strong hypomorph or a complete loss-of-function. Our experimental data provide strong support for the molecular diagnosis and pathogenicity of the NBEA p.Gly1967Arg variant and the importance of the DUF1088 for NBEA function.

Indexed as

Genetic VariationAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCarrier ProteinsChildEpilepsyFemaleGene EditingHumansNerve Tissue ProteinsNeurodevelopmental DisordersPathology, MolecularPotassium ChannelsCaenorhabditis elegans ProteinsCarrier ProteinsNBEA protein, humanNerve Tissue ProteinsPotassium ChannelsSEL-2 protein, C elegansC. elegansEpilepsyNeurobeachinNeurodevelopmental delaySEL-2

Identifiers

PMID34412939
PMCPMC10626981
OpenAlexW3191451502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.